Human Genome Sciences hgsi.com

Human Genome Sciences is a development stage company that was formed to develop and commercialize therapeutically enhanced proprietary biopharmaceuticals with the aim of offering significant reductions in dosage, injection frequency, side effects, and overall cost of treatment. In July 2012, Human Genome Sciences was acquired by GlaxoSmithKline. The valuation of Human Genome Sciences was $3.6 billion.

Human Genome Sciences is a development stage company that was formed to develop and commercialize therapeutically enhanced proprietary biopharmaceuticals with the aim of offering significant reductions in dosage, injection frequency, side effects, an...Show all

See All Exits Recent Exits

Phone:

Fax:

14200 Shady Grove Road

Rockville, 20850
Maryland, United States

Human Genome Sciences - Investments & Acquisitions

Show Real Data Human Genome Sciences Investments